SUNSHINE LAKE PHARMA_Providing professional financial news and data related to SUNSHINE LAKE PHARMA, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SUNSHINE LAKE PHARMA (06887.HK): Expected H‑1 Loss to Widen Year‑on‑Year

Tags：

SUNSHINE LAKE PHARMA 06887.HK

2026-08-25

Finance
EuroEyes (01846.HK): Expected H‑1 Loss of HK$10 Million‑HK$17 Million
Finance
Jiaxin International Resources (03858.HK): Signs Bakuta Mining Construction Contract Worth Approximately RMB 257 Million
Finance
TCL Electronics (01070.HK): Proposes Spin‑off and Separate Listing of its Photovoltaic Business
Finance
Hengrui Pharmaceuticals (01276.HK): NDA for HRG2010 Capsules Accepted
Finance
Leader Education (01449.HK): Enters into AI‑Education Strategic Cooperation with NeuralFin
Finance
SDMC (00901.HK): Included as a Constituent Stock of Hang Seng Composite Index
Finance
SUNSHINE LAKE PHARMA (06887.HK): Expected H‑1 Loss to Widen Year‑on‑Year
Finance
Newtrend (02573.HK): Signs Construction Contract for Ji’an Production Plant Worth Approximately RMB 110 Million
Finance
CNGR Advanced Material (02579.HK): Proposed Change in Use of Proceeds from Global H‑Share Offering
Finance
CONTIOCEAN (02613.HK): Proposes to Participate in Public Tender for Acquisition of Assets in Nantong, Jiangsu

Scan QR Code

Download App